Erschienen in:
03.05.2017 | Family Planning (A Burke, Section Editor)
Non-Contraceptive Benefits of Hormonal Contraception: Established Benefits and New Findings
verfasst von:
Ashley R. Brant, Peggy Peng Ye, Stephanie J. Teng, Pamela S. Lotke
Erschienen in:
Current Obstetrics and Gynecology Reports
|
Ausgabe 2/2017
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
The majority of women who use contraception acknowledge the non-contraceptive benefits and many women use contraception solely for these benefits. The purpose of this review is to discuss the established benefits and highlight recent advances in our understanding of non-contraceptive benefits.
Recent Findings
Combined hormonal contraception (CHC), especially extended-cycle CHC, provides significant improvement for women suffering from heavy menstrual bleeding, pelvic pain, menstrual migraines, and mood disorders. The levonorgestrel intrauterine device (LNG IUD) provides improvement in pain and bleeding beyond that of CHC although its effectiveness may be mediated by pre-existing bleeding patterns. CHC and LNG IUD are protective against gynecologic cancers and data continues to emerge on non-gynecologic cancer risk. Hyperandrogenism is best treated with CHC containing newer progestins. LNG IUD may be used in the treatment of endometrial hyperplasia or carcinoma and is effective for endometrial protection during estrogen replacement. CHCs promote healthy vaginal flora.
Summary
Counseling on contraception should include a discussion of both the risks and benefits. In most women, the benefits are substantial and outweigh the risks.